# Drug-gene-nutraceutical Interactions of Cannabidiol and Tacrolimus

> **NCT05490511** · PHASE1 · COMPLETED · sponsor: **Indiana University** · enrollment: 57 (actual)

## Conditions studied

- CBD
- Transplant Complication
- Kidney Disease, Chronic

## Interventions

- **DRUG:** Tacrolimus single dose
- **DRUG:** Epidiolex single dose
- **DRUG:** Epidiolex steady-state and tacrolimus single dose

## Key facts

- **NCT ID:** NCT05490511
- **Lead sponsor:** Indiana University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-10-31
- **Primary completion:** 2025-08-31
- **Final completion:** 2025-08-31
- **Target enrollment:** 57 (ACTUAL)
- **Last updated:** 2026-02-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05490511

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05490511, "Drug-gene-nutraceutical Interactions of Cannabidiol and Tacrolimus". Retrieved via AI Analytics 2026-08-17 from https://api.ai-analytics.org/clinical/NCT05490511. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*